← Back
Data updated: Mar 29, 2026
FOUGERA
CardiovascularNeurologyImmunology
Generics
FOUGERA is a generic drug manufacturer focused on Cardiovascular, Neurology, Immunology.
1997
Since
4
Drugs
-
Trials
12
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 30%
1 drugs
Neurology 30%
1 drugs
Immunology 20%
0 drugs Phase 3: 1
Dermatology 20%
0 drugs Phase 3: 1
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Competitors by Therapeutic Area
PAI HOLDINGS PHARM big-pharma
Dermatology, Neurology, Cardiovascular, Immunology
Eli Lilly big-pharma
Immunology, Neurology, Dermatology
BAUSCH specialty
Dermatology, Immunology, Cardiovascular
ADVANZ PHARMA big-pharma
Immunology, Neurology, Cardiovascular, Dermatology
COSETTE other
Cardiovascular, Dermatology, Immunology
Active (2)
Discontinued (2)
Company Info
- First Approval
- 1997-03-25
- Latest
- 1999-12-13
- Applications
- 7